Copyright Reports & Markets. All rights reserved.

Global Latanoprost for Open-angle Glaucoma Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Latanoprost for Open-angle Glaucoma Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Brand Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Formulation Type
    • 1.4.1 Overview: Global Latanoprost for Open-angle Glaucoma Consumption Value by Formulation Type: 2021 Versus 2025 Versus 2032
    • 1.4.2 Monotherapy Ophthalmic Solution
    • 1.4.3 Ophthalmic Emulsion
    • 1.4.4 Others
  • 1.5 Market Analysis by Sales Channel
    • 1.5.1 Overview: Global Latanoprost for Open-angle Glaucoma Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
    • 1.5.2 Online
    • 1.5.3 Offline
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Latanoprost for Open-angle Glaucoma Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Clinic
    • 1.6.4 Other
  • 1.7 Global Latanoprost for Open-angle Glaucoma Market Size & Forecast
    • 1.7.1 Global Latanoprost for Open-angle Glaucoma Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Latanoprost for Open-angle Glaucoma Sales Quantity (2021-2032)
    • 1.7.3 Global Latanoprost for Open-angle Glaucoma Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Viatris
    • 2.1.1 Viatris Details
    • 2.1.2 Viatris Major Business
    • 2.1.3 Viatris Latanoprost for Open-angle Glaucoma Product and Services
    • 2.1.4 Viatris Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Viatris Recent Developments/Updates
  • 2.2 Sandoz
    • 2.2.1 Sandoz Details
    • 2.2.2 Sandoz Major Business
    • 2.2.3 Sandoz Latanoprost for Open-angle Glaucoma Product and Services
    • 2.2.4 Sandoz Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sandoz Recent Developments/Updates
  • 2.3 Apotex
    • 2.3.1 Apotex Details
    • 2.3.2 Apotex Major Business
    • 2.3.3 Apotex Latanoprost for Open-angle Glaucoma Product and Services
    • 2.3.4 Apotex Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Apotex Recent Developments/Updates
  • 2.4 Teva
    • 2.4.1 Teva Details
    • 2.4.2 Teva Major Business
    • 2.4.3 Teva Latanoprost for Open-angle Glaucoma Product and Services
    • 2.4.4 Teva Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Recent Developments/Updates
  • 2.5 Taj Pharma
    • 2.5.1 Taj Pharma Details
    • 2.5.2 Taj Pharma Major Business
    • 2.5.3 Taj Pharma Latanoprost for Open-angle Glaucoma Product and Services
    • 2.5.4 Taj Pharma Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Taj Pharma Recent Developments/Updates
  • 2.6 China Resources Zizhu Pharmaceutical
    • 2.6.1 China Resources Zizhu Pharmaceutical Details
    • 2.6.2 China Resources Zizhu Pharmaceutical Major Business
    • 2.6.3 China Resources Zizhu Pharmaceutical Latanoprost for Open-angle Glaucoma Product and Services
    • 2.6.4 China Resources Zizhu Pharmaceutical Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 China Resources Zizhu Pharmaceutical Recent Developments/Updates
  • 2.7 Thea Pharma
    • 2.7.1 Thea Pharma Details
    • 2.7.2 Thea Pharma Major Business
    • 2.7.3 Thea Pharma Latanoprost for Open-angle Glaucoma Product and Services
    • 2.7.4 Thea Pharma Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Thea Pharma Recent Developments/Updates
  • 2.8 Bausch & Lomb Incorporated
    • 2.8.1 Bausch & Lomb Incorporated Details
    • 2.8.2 Bausch & Lomb Incorporated Major Business
    • 2.8.3 Bausch & Lomb Incorporated Latanoprost for Open-angle Glaucoma Product and Services
    • 2.8.4 Bausch & Lomb Incorporated Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bausch & Lomb Incorporated Recent Developments/Updates
  • 2.9 Sun Pharma
    • 2.9.1 Sun Pharma Details
    • 2.9.2 Sun Pharma Major Business
    • 2.9.3 Sun Pharma Latanoprost for Open-angle Glaucoma Product and Services
    • 2.9.4 Sun Pharma Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sun Pharma Recent Developments/Updates
  • 2.10 Santen Pharmaceutical
    • 2.10.1 Santen Pharmaceutical Details
    • 2.10.2 Santen Pharmaceutical Major Business
    • 2.10.3 Santen Pharmaceutical Latanoprost for Open-angle Glaucoma Product and Services
    • 2.10.4 Santen Pharmaceutical Latanoprost for Open-angle Glaucoma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Santen Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Latanoprost for Open-angle Glaucoma by Manufacturer

  • 3.1 Global Latanoprost for Open-angle Glaucoma Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Latanoprost for Open-angle Glaucoma Revenue by Manufacturer (2021-2026)
  • 3.3 Global Latanoprost for Open-angle Glaucoma Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Latanoprost for Open-angle Glaucoma by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Latanoprost for Open-angle Glaucoma Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Latanoprost for Open-angle Glaucoma Manufacturer Market Share in 2025
  • 3.5 Latanoprost for Open-angle Glaucoma Market: Overall Company Footprint Analysis
    • 3.5.1 Latanoprost for Open-angle Glaucoma Market: Region Footprint
    • 3.5.2 Latanoprost for Open-angle Glaucoma Market: Company Product Type Footprint
    • 3.5.3 Latanoprost for Open-angle Glaucoma Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Latanoprost for Open-angle Glaucoma Market Size by Region
    • 4.1.1 Global Latanoprost for Open-angle Glaucoma Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Latanoprost for Open-angle Glaucoma Consumption Value by Region (2021-2032)
    • 4.1.3 Global Latanoprost for Open-angle Glaucoma Average Price by Region (2021-2032)
  • 4.2 North America Latanoprost for Open-angle Glaucoma Consumption Value (2021-2032)
  • 4.3 Europe Latanoprost for Open-angle Glaucoma Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Latanoprost for Open-angle Glaucoma Consumption Value (2021-2032)
  • 4.5 South America Latanoprost for Open-angle Glaucoma Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Latanoprost for Open-angle Glaucoma Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Latanoprost for Open-angle Glaucoma Sales Quantity by Type (2021-2032)
  • 5.2 Global Latanoprost for Open-angle Glaucoma Consumption Value by Type (2021-2032)
  • 5.3 Global Latanoprost for Open-angle Glaucoma Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Latanoprost for Open-angle Glaucoma Sales Quantity by Application (2021-2032)
  • 6.2 Global Latanoprost for Open-angle Glaucoma Consumption Value by Application (2021-2032)
  • 6.3 Global Latanoprost for Open-angle Glaucoma Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Latanoprost for Open-angle Glaucoma Sales Quantity by Type (2021-2032)
  • 7.2 North America Latanoprost for Open-angle Glaucoma Sales Quantity by Application (2021-2032)
  • 7.3 North America Latanoprost for Open-angle Glaucoma Market Size by Country
    • 7.3.1 North America Latanoprost for Open-angle Glaucoma Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Latanoprost for Open-angle Glaucoma Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Latanoprost for Open-angle Glaucoma Sales Quantity by Type (2021-2032)
  • 8.2 Europe Latanoprost for Open-angle Glaucoma Sales Quantity by Application (2021-2032)
  • 8.3 Europe Latanoprost for Open-angle Glaucoma Market Size by Country
    • 8.3.1 Europe Latanoprost for Open-angle Glaucoma Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Latanoprost for Open-angle Glaucoma Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size by Region
    • 9.3.1 Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Latanoprost for Open-angle Glaucoma Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Latanoprost for Open-angle Glaucoma Sales Quantity by Type (2021-2032)
  • 10.2 South America Latanoprost for Open-angle Glaucoma Sales Quantity by Application (2021-2032)
  • 10.3 South America Latanoprost for Open-angle Glaucoma Market Size by Country
    • 10.3.1 South America Latanoprost for Open-angle Glaucoma Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Latanoprost for Open-angle Glaucoma Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Latanoprost for Open-angle Glaucoma Market Size by Country
    • 11.3.1 Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Latanoprost for Open-angle Glaucoma Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Latanoprost for Open-angle Glaucoma Market Drivers
  • 12.2 Latanoprost for Open-angle Glaucoma Market Restraints
  • 12.3 Latanoprost for Open-angle Glaucoma Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Latanoprost for Open-angle Glaucoma and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Latanoprost for Open-angle Glaucoma
  • 13.3 Latanoprost for Open-angle Glaucoma Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Latanoprost for Open-angle Glaucoma Typical Distributors
  • 14.3 Latanoprost for Open-angle Glaucoma Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Latanoprost for Open-angle Glaucoma market size was valued at US$ 1083 million in 2025 and is forecast to a readjusted size of US$ 1315 million by 2032 with a CAGR of 2.8% during review period.
    Latanoprost for open-angle glaucoma refers to latanoprost-based ophthalmic formulations, mainly 0.005% eye drops or ophthalmic emulsion, used to reduce elevated intraocular pressure in patients with open-angle glaucoma. Latanoprost is a prostaglandin F2α analogue and is commonly used once daily, making it suitable for long-term glaucoma management. Its upstream supply chain includes prostaglandin chiral intermediates, esterification reagents, solvents, buffer salts, preservatives or preservative-free packaging systems, purified water, LDPE ophthalmic bottles and secondary packaging materials. Downstream demand mainly comes from hospital ophthalmology departments, ophthalmic clinics, retail pharmacies, online prescription refill channels and chronic glaucoma follow-up management.
    In 2025, global latanoprost for open-angle glaucoma production reached approximately 350 million units, with an average global market price is $3 per unit.
    Latanoprost for open-angle glaucoma is a prostaglandin analogue used to reduce intraocular pressure in patients with open-angle glaucoma. It is mainly supplied as a 0.005% ophthalmic solution. Its mechanism is based on activation of prostaglandin FP receptors and enhancement of aqueous humor outflow, particularly through the uveoscleral pathway, thereby lowering intraocular pressure. The FDA-approved XALATAN label states that latanoprost is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, with the usual dosing regimen of one drop in the affected eye or eyes once daily in the evening.
    Within open-angle glaucoma treatment, latanoprost is one of the foundational first-line intraocular-pressure-lowering therapies. Compared with beta blockers, carbonic anhydrase inhibitors, and alpha agonists, prostaglandin analogues generally offer once-daily dosing, proven pressure-lowering efficacy, relatively limited systemic adverse effects, and extensive long-term clinical experience. The NICE BNF treatment summary also lists topical prostaglandin analogues, including latanoprost, tafluprost, travoprost, and bimatoprost, as first-line treatment options for glaucoma and ocular hypertension. The AAO 2025 Primary Open-Angle Glaucoma Preferred Practice Pattern notes that a reasonable initial treatment goal for POAG patients is usually a 20%–30% reduction in IOP from baseline, with further adjustment according to disease course.
    From a market-development perspective, Latanoprost for Open-angle Glaucoma has entered a mature generic-competition stage. Originator brands still retain clinical recognition and brand inertia, but market growth is increasingly driven by a larger patient base, population aging, improved diagnosis rates, long-term adherence management, and penetration in emerging markets. Because glaucoma treatment is typically long term and often lifelong, price, accessibility, ocular comfort, preservative-related ocular-surface irritation, packaging convenience, and patient adherence are becoming important competitive factors.
    This report is a detailed and comprehensive analysis for global Latanoprost for Open-angle Glaucoma market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Latanoprost for Open-angle Glaucoma market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Latanoprost for Open-angle Glaucoma market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Latanoprost for Open-angle Glaucoma market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Latanoprost for Open-angle Glaucoma market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Latanoprost for Open-angle Glaucoma
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Latanoprost for Open-angle Glaucoma market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viatris, Sandoz, Apotex, Teva, Taj Pharma, China Resources Zizhu Pharmaceutical, Thea Pharma, Bausch & Lomb Incorporated, Sun Pharma, Santen Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Latanoprost for Open-angle Glaucoma market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Brand Drug
    Generic Drug
    Market segment by Formulation Type
    Monotherapy Ophthalmic Solution
    Ophthalmic Emulsion
    Others
    Market segment by Sales Channel
    Online
    Offline
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Viatris
    Sandoz
    Apotex
    Teva
    Taj Pharma
    China Resources Zizhu Pharmaceutical
    Thea Pharma
    Bausch & Lomb Incorporated
    Sun Pharma
    Santen Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Latanoprost for Open-angle Glaucoma product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Latanoprost for Open-angle Glaucoma, with price, sales quantity, revenue, and global market share of Latanoprost for Open-angle Glaucoma from 2021 to 2026.
    Chapter 3, the Latanoprost for Open-angle Glaucoma competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Latanoprost for Open-angle Glaucoma breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Latanoprost for Open-angle Glaucoma market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Latanoprost for Open-angle Glaucoma.
    Chapter 14 and 15, to describe Latanoprost for Open-angle Glaucoma sales channel, distributors, customers, research findings and conclusion.

    Buy now